Access Bio엑세스바이오
950130 · KOSDAQ · ₩950130 · 엑세스바이오
₩1,920▼ ₩40 (2.04%)End-of-day · Oct 29, 2026 · End-of-day prices.
Filings
- Major sales or supply contract단일판매ㆍ공급계약체결Oct 20, 2026Open on DART
Predicted impact: Medium
Supply contract filed with no size given; last year's revenue was tiny, so even a small order may be large.
- Half-year report (Jun 2026)반기보고서 (2026.06)Aug 14, 2026Open on DART
- Amended: Lawsuit filed or ruled[기재정정]소송등의제기ㆍ신청(일정금액이상의청구) (손해배상 청구)Jul 7, 2026Open on DART
- Amended: Annual report (Dec 2025)[기재정정]사업보고서 (2025.12)Jun 23, 2026Open on DART
- Quarterly report (Mar 2026)분기보고서 (2026.03)May 15, 2026Open on DART
- Amended: Share cancellation decision[기재정정]주식소각결정Apr 30, 2026Open on DART
- Amended: Acquisition of shares in another company[기재정정]타법인주식및출자증권취득결정Apr 15, 2026Open on DART
- Change of Head Office Location본점소재지변경Mar 31, 2026Open on DART
- Annual general meeting results정기주주총회결과Mar 31, 2026Open on DART
- Report on Appointment, Dismissal, or Mid-Term Resignation of Independent Directors독립이사의선임ㆍ해임또는중도퇴임에관한신고Mar 31, 2026Open on DART
- Amended: Acquisition of shares in another company[기재정정]타법인주식및출자증권취득결정Mar 27, 2026Open on DART
- Amended: Audit report submitted[기재정정]감사보고서제출Mar 24, 2026Open on DART
- Audit report submitted감사보고서제출Mar 23, 2026Open on DART
- Annual report (Dec 2025)사업보고서 (2025.12)Mar 23, 2026Open on DART
- Amended: Shareholders' meeting called[기재정정]주주총회소집결의Mar 12, 2026Open on DART
- Shareholders' meeting called주주총회소집결의Mar 12, 2026Open on DART
- Reference Document for Proxy Solicitation of Voting Rights의결권대리행사권유참고서류Mar 12, 2026Open on DART
- Notice of shareholders' meeting주주총회소집공고Mar 12, 2026Open on DART
- Change in Revenue or Profit/Loss Structure of 30% or More (15% or More for Large Companies)매출액또는손익구조30%(대규모법인은15%)이상변동Feb 24, 2026Open on DART
- 5%+ holding report주식등의대량보유상황보고서(일반)Jan 29, 2026Open on DART
- Insider shareholding report임원ㆍ주요주주특정증권등소유상황보고서Jan 29, 2026Open on DART
- Insider shareholding report임원ㆍ주요주주특정증권등소유상황보고서Jan 29, 2026Open on DART
- Acquisition of shares in another company타법인주식및출자증권취득결정Jan 19, 2026Open on DART
- Report on Appointment, Dismissal, or Mid-Term Resignation of Independent Directors독립이사의선임ㆍ해임또는중도퇴임에관한신고Dec 17, 2025Open on DART
- Other management matters기타경영사항(자율공시) (제24기 정기주주총회 권리주주 확정을 위한 증권예탁증권 기준일 설정 공고)Dec 12, 2025Open on DART
- Quarterly report (Sep 2025)분기보고서 (2025.09)Nov 14, 2025Open on DART
- 5%+ holding report주식등의대량보유상황보고서(일반)Oct 22, 2025Open on DART
- Insider shareholding report임원ㆍ주요주주특정증권등소유상황보고서Oct 22, 2025Open on DART
- 5%+ holding report주식등의대량보유상황보고서(일반)Oct 15, 2025Open on DART
- Insider shareholding report임원ㆍ주요주주특정증권등소유상황보고서Oct 15, 2025Open on DART
- Insider shareholding report임원ㆍ주요주주특정증권등소유상황보고서Oct 15, 2025Open on DART
- Share cancellation decision주식소각결정Sep 29, 2025Open on DART
- Trading halt주권매매거래정지해제 (상장적격성 실질심사 대상 제외 결정)Sep 26, 2025Open on DART
- Other Market Notice (Exclusion from Substantive Review of Listing Eligibility)기타시장안내 (상장적격성 실질심사 대상 제외 결정)Sep 26, 2025Open on DART
- Other Market Notice (Extension of Investigation Period to Determine Whether Substantive Review Applies)기타시장안내 (실질심사 대상여부 결정을 위한 조사기간 연장 안내)Sep 5, 2025Open on DART
- Market Notice (Guidance on Deadline for Decision Subject to Substantive Review of Listing Eligibility)기타시장안내 (상장적격성 실질심사 대상결정 기한 안내 )Aug 18, 2025Open on DART
- Other Market Notice (Related to Substantive Review of Listing Eligibility)기타시장안내 (상장적격성 실질심사 관련)Aug 14, 2025Open on DART
- Trading halt주권매매거래정지 (상장적격성 실질심사 대상 (사유발생))Aug 14, 2025Open on DART
- Occurrence of Semi-Annual or Quarterly Revenue Shortfall반기또는분기매출액미달사실발생Aug 14, 2025Open on DART
- Half-year report (Jun 2025)반기보고서 (2025.06)Aug 14, 2025Open on DART
- Amended: Annual report (Dec 2024)[기재정정]사업보고서 (2024.12)Aug 14, 2025Open on DART
- [Amended] Notice of Stock Purchase Option Grant[기재정정]주식매수선택권부여에관한신고May 20, 2025Open on DART
- Quarterly report (Mar 2025)분기보고서 (2025.03)May 15, 2025Open on DART
- 5%+ holding report주식등의대량보유상황보고서(일반)Apr 7, 2025Open on DART
- Annual general meeting results정기주주총회결과Mar 26, 2025Open on DART
- Report on Appointment, Dismissal, or Mid-Term Resignation of Independent Directors독립이사의선임ㆍ해임또는중도퇴임에관한신고Mar 26, 2025Open on DART
- Audit report submitted감사보고서제출Mar 18, 2025Open on DART
- Annual report (Dec 2024)사업보고서 (2024.12)Mar 18, 2025Open on DART
- Shareholders' meeting called주주총회소집결의Mar 11, 2025Open on DART
- Reference Document for Proxy Solicitation of Voting Rights의결권대리행사권유참고서류Mar 11, 2025Open on DART
Titles in Korean until English translations are added.
Also known as: Access Bio / 엑세스바이오 / 950130 / KRX:950130
Source: KRX statistical information